Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Meetings

Virtual Education Program

  • Presentations from the EHA2022 Congress

    Watch here

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

    Watch here

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

    Watch here

  • COLT Meeting 2019: CML related topics

    Watch here

  • COLT Meeting 2019: The CML frontier

    Watch here

    Virtual Education Program - COLT Meeting 2014 (Session 2)

     

    Jorge Cortes 2013                     Prof. Jorge Cortes                             

     

     

        Session 2: Optimizing Therapy in CML

    • Evolution of frontline therapy in CML
    • Treatment outcomes for different time periods
    • Factors predicting optimal response
    • Treatment choices in CML including 2nd/3rd generation of TKI's
    • Risks and outcomes after treatment discontinuation